Parasite vaccines - A reality?

Veterinary Parasitology

Volumn 98, Issue 1-3, 2001, Pages 149-167

  Dalton, J P ^a   Mulcahy, Grace ^b  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Ectoparasite; Helminth; Parasites; Protozoans; Vaccines; Veterinary

Indexed keywords

ANAPLASMOSIS VACCINE; ANTIPARASITIC AGENT; COCCIVAX; DICTYOCAULUS VACCINE; GAVAC; GIARDIA VAX; HUSKVAC; IMMUNOCOX; LIVACOX; PARACOX; TICKGARD; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANAPLASMOSIS; ANIMAL FOOD; ANIMAL WELFARE; CATTLE DISEASE; COCCIDIOSIS; CONSUMER; CYSTICERCOSIS; DRUG MARKETING; ECHINOCOCCOSIS; ENVIRONMENT; FASCIOLA HEPATICA; FASCIOLIASIS; GENOME; GIARDIASIS; HAEMONCHUS CONTORTUS; NONHUMAN; OSTERTAGIA; PARASITOSIS; PROTOZOON; REVIEW; TOXOPLASMOSIS; TRICHOSTRONGYLUS; VACCINE PRODUCTION; WORM INFECTION;

EID: 0035850249     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(01)00430-7     Document Type: Article

References (102)

1. DNA vaccines: Technology and application as anti-parasite and anti-microbial agents
2. Immunology of human helminth infections
3. Vaccination of sheep against haemonchosis with H11 - Prevention of the periparturient rise and colostral transfer of protective immunity
4. Duration of protective immunity against ovine haemonchosis following vaccination with the nematode gut membrane antigen H11
5. Cell: Sporozoite interactions and invasion by apicocomplexan parasites of the genus Eimeria
6. Irradiated vaccines for helminth control in livestock
7. Worm control and anthelminthic resistance: Adventures with a model
8. Parasite proteomics
9. Fibrinogen-degrading proteins from Haemonchus contortus used to vaccinate sheep
10. Cross-regulation of immune responses in mice infected with Th2-inducing Fasciola hepatica and Th1-inducing Bordetella pertussis
11. Large scale production in Pichia pastoralis of the recombinat vaccine Gavac™ against cattle tick
12. Salmonella typhimurium as a basis for a live oral Echinococcus granulosis vaccine
13. Application of genomics and proteomics for identification of bacterial gene products as potential vaccine candidates
14. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella
15. Humoral immune responses and safety of experimental formulations of inactivated Neospora vaccines
16. CpG DNA as a Th1-promoting adjuvant in immunization against Tyrpanosoma cruzi
17. Control of coccidiosis: Lessons from other sporozoa
18. Molecular cloning and sequencing of a cysteine protease expressed by Haemonchus contortus adult worms
19. Cross-protection against four species of chicken Coccidia with a single recombinant antigen
20. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteases and haemoglobin
21. Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy
22. Humoral immune responses to DNA vaccines expressing secreted membrane bound and non-secreted forms of the Taenia ovis 45w antigen
23. Vaccination against worm parasites of animals
24. A developmentally regulated gene of Echinococcus granulosus codes for a 15.5 kDa polypeptide related to fatty acid binding proteins
25. Baterial toxins as mucosal adjuvants
26. Towards a permanent solution for controlling cattle ticks
27. Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus
28. Galectins from sheep gastrointestinal nematodes are highly conserved
29. Haemonchus contortus glycoproteins contain oligosaccharides with novel highly fucosylated core structures
30. Antigen delivery strategies for mucosal vaccines
31. Evaluation of three 'Ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production
32. Vaccination against the gastrointestinal nematode Haemonchus contortus using a purified larval surface antigen
33. Protective immunity to Haemonchus contortus induced by immunoaffinity isolated antigens that share a phylogenetically conserved carbohydrate gut surface epitope
34. Haemonchus contortus GA1 antigens: Related phospholipase C-sensitive, apical gut membrane proteins encoded as a polyprotein and released from the nematode during infection
35. Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen
36. Protection against Coccidiosis in out-bred chickens elicited by gamma-irradiated Eimeria maxima
37. Vaccination against ovine cysticercosis using a recombinant antigen
38. +T lymphocytes contribute to protective immunity induced in sheep and goats by Haemonchus contortus gut antigens
39. Immunological control of gastrointestinal nematode infections
40. Vaccination against gastrointestinal nematodes using gut-expressed antigens
41. Characterisation of proteases in extracts of adult Haemonchus contortus, the ovine abomasal nematode
42. The contribution of molecular biology to the development of vaccines against nematode and trematode parasites of domestic ruminants
43. Successful DNA immunisation of rats against fasciolosis
44. Protection in lambs vaccinated with Haemonchus contortus antigens is age related, and correlates with IgE rather than IgG1 antibody
45. Immune effects and mechanism of action of CpG motifs
46. Schistosoma mansoni: Pathological and clinical aspects
47. Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis
48. Vaccination against cysticercosis and hydatid disease
49. Isolation of Fasciola hepatica haemoglobin
50. Rational design of nematode vaccines: Natural antigens
51. Heterogeneity of cytokine secretion patterns and function of helper cells
52. Two types of murine helper T cell clone. I. Definition according to profiles of lymphocyte activities and secreted proteins
53. Correlation of specific antibody titre and antibody avidity with protection in cattle immunised against Fasciola hepatica
54. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines
55. Immunology of Fasciola hepatica infection
56. A helical, polymeric extracellular protein associated with the luminal surface of Haemonchus contortus intestinal cells
57. Vaccination of young lambs by means of a protein fraction extracted from adult Haemonchus contortus
58. Sequence analysis of a Fasciola hepatica cDNA clone
59. Fasciola hepatica: Vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins
60. The development of vaccines against gastrointestinal nematodes, particularly Haemonchus contortus
61. cDNA cloning of galectins from the third stage larvae of the parasitic nematode Teladorsagia circumcincta
62. Giardia vaccination
63. Vaccination with cathepsin L proteases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep
64. A developmentally regulated cysteine protease gene family in Haemonchus contortus
65. Cloning and sequence comparison of four distinct cysteine proteases expressed by Haemonchus contortus adult worms
66. Isolation of putative cysteine protease genes of Ostertagia ostertagi
67. Application of molecular biology in veterinary parasitology
68. Immunological control of arthropod ectoparasites - A review
69. Stage-specific expression of surface molecules by the larval stages of Haemonchus contortus
70. Fully mobilizing host defense: Building better vaccines
71. Expression of Haemonchus contortus pepsinogen in Caenorhabditis elegans
72. A tissue specific approach for analysis of membrane and secreted proteins from Haemonchus contortus gut and its application to diverse nematode species
73. Developmentally regulated secretion of cathepsin L-like proteases by Haemonchus contortus
74. Extracellular matrix: A tool for defining extracorporeal digestion of parasite proteases
75. Taenia ovis recombinant vaccine - Quo vadit
76. Immunisation against experimental coccidiosis produces contrasting results in inbred mice of differing susceptibility to infection
77. Impairment of tetanus toxoid-specific Th1 like immune responses in humans infected with Schistosoma mansoni
78. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses
79. Protective immunity induced by vaccination with two Haemonchus contortus excretory secretory proteins in sheep
80. Cloning and characterisation of glutamate dehydrogenase (GDH) from the gut of Haemonchus contortus
81. Molecular cloning and characterisation of gut-derived cysteine proteases associated with a host-protective extract from Haemonchus contortus
82. Prospects for vaccines of helminth parasites of grazing ruminants
83. Purification and evaluation of the integral membrane protein H11 as a protective antigen against Haemonchus contortus
84. Maternal transfer of antibodies induced by infection with Eimeria maxima partially protects chickens against challenge with Eimeria tenella
85. Protection studies with integral membrane fractions of Haemonchus contortus
86. Cloning and characterisation of a microsomal aminopeptidase from the intestine of the nematode Haemonchus contortus
87. Evaluation of immunization with gut membrane glycoproteins of Ostertagia ostertagi against homologous challenge in calves and against Haemonchus contortus in sheep
88. Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: Effects of mode of vaccination and the cellular compartment of antigen expression
89. A DNA vaccine encoding a conserved Eimeria protein induces protective immunity against live Eimeria acervulina challenge
90. Progress in development of liver fluke vaccines
91. Development of vaccines against Fasciola hepatica
92. Core alpha 1-3-fucose is a common modification of N-glycans in parasitic helminthes and constitutes an important epitope of IgE from Haemonchus contortus infected sheep
93. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments
94. Progress in recombinant vaccine development against coccidiosis: Review and prospects into the next millennium
95. New strategies for using mucosal vaccination to achieve more effective immunisation
96. Eimeria maxima gametocyte antigens: Potential use in a subunit maternal vaccine against coccidiosis in chickens
97. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity
98. Commercialisation of a recombinant vaccine against Boophilus microplus
99. Immune modulation by cholera-like enterotoxins: From adjuvant to therapeutic
100. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes